New MRI technique aims to spot kidney scarring Non-Invasively

NCT ID NCT04508049

Ongoing Diagnosis Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new type of MRI scan (qMT-MRI) to see if it can detect scarring in the kidneys of people with high blood pressure and narrowed kidney arteries. Researchers will compare the scan results to kidney function and injury markers. If it works, this could offer a safer, needle-free way to assess kidney damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: qMT-MRI scan
What this could lead to: If successful, this MRI technique could become a non-invasive way to detect kidney scarring early, helping doctors predict recovery and guide treatment without needing a biopsy.
What could go wrong: This is a small, early feasibility study with only 24 participants. The MRI technique may not prove accurate enough for routine use, and results may not apply to all patients with kidney disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder renal artery disease renovascular hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION RENOVASCULAR

Contacts and locations

Locations

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.